Monthly Archives: July 2010

The Day After – the FDA Avandia Meeting

 The Thursday morning quarterbacking begins! Actually I did not attend the meetings.  I did, however, thanks to eagle eye buddy Brian Reid (@brianreid) who gave the heads up on Twitter that CNN was actually running video of the meeting (unprecedented … Continue reading

Posted in Uncategorized | Comments Off on The Day After – the FDA Avandia Meeting

Should There be an App for Reporting Adverse Events?

Today the United States Department of Agriculture (USDA) announced the launch of a new app for smartphones that will alert consumers to the latest recall information in one spot, allowing them to track and actually see recalled products.  This means … Continue reading

Posted in Uncategorized | 2 Comments

IOM – Ethical Issues in Studying Safety of Approved Drugs

Just as an FDA Advisory Committee is mixing a batch of Avandia soup at a hearing held today to discuss and review the post-marketing safety of the drug, the Institute of Medicine (IOM) has issued a letter report on the … Continue reading

Posted in Uncategorized | Comments Off on IOM – Ethical Issues in Studying Safety of Approved Drugs

The XVIII International AIDS Conference – Everything Has Changed

 Next Sunday the opening session of the XVIII International AIDS Conference will take place in Vienna, Austria.  The conference, which used to be an annual conference and is now biannual, will bring together clinical research scientists, social scientists, health educators … Continue reading

Posted in Uncategorized | Comments Off on The XVIII International AIDS Conference – Everything Has Changed

A Food and Drug Administration Facebook Page?

For a long time, I have been an advocate for the FDA to open up a Facebook page.  There are a lot of reasons, but first and foremost is a recognition that social media has changed the way we communicate … Continue reading

Posted in Uncategorized | 12 Comments